Using both conditional genetic inactivation of VIPR2 in ILC3 and chemogenetic-mediated inhibition of VIP-producing neurons, we found that hepatic steatosis can be attenuated by modulation of VIPergic signaling in innate lymphoid cells. The gene discussed is VIPR2; the disease is fatty liver disease.